These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 28050755)

  • 1. Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs).
    Hakeam HA; Al-Sanea N
    J Thromb Thrombolysis; 2017 Apr; 43(3):343-351. PubMed ID: 28050755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review.
    Bikdeli B; Zahedi Tajrishi F; Sadeghipour P; Talasaz AH; Fanikos J; Lippi G; Siegal DM; Eikelboom JW; Monreal M; Jimenez D; Connors JM; Ageno W; Barnes GD; Piazza G; Angiolillo DJ; Parikh SA; Kirtane AJ; Lopes RD; Bhatt DL; Weitz JI; Mehran R; Krumholz HM; Goldhaber SZ; Lip GYH
    JAMA Cardiol; 2022 Jul; 7(7):747-759. PubMed ID: 35648414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Acting Oral Anticoagulants Following Gastrointestinal Tract Surgery.
    Hakeam HA; Alkhani M; Alyahya Z; Alawaji Z; Ofori S
    J Cardiovasc Pharmacol; 2021 Dec; 78(6):867-874. PubMed ID: 34882113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New direct oral oral anticoagulants (DOACs) - indications of DOACs].
    Darius H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Mar; 49(3):182-90; quiz 191. PubMed ID: 24711238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Prescribing Practices and Outcomes Using Direct-acting Oral Anticoagulants After Cardiac Surgery.
    Kanaan DM; Cook BM; Kelly J; Malloy R
    Clin Ther; 2021 Jun; 43(6):e209-e216. PubMed ID: 34078556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran.
    Leung TS; Law EH
    Drug Des Devel Ther; 2015; 9():3557-69. PubMed ID: 26185422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events in patients taking apixaban or rivaroxaban who have undergone bariatric surgery: a retrospective case series.
    DeCamillo D; Haymart B; Barnes GD
    J Thromb Thrombolysis; 2022 Apr; 53(3):601-606. PubMed ID: 34559367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
    Am J Cardiol; 2016 Jul; 118(2):210-4. PubMed ID: 27236255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups.
    Lip GY; Mitchell SA; Liu X; Liu LZ; Phatak H; Kachroo S; Batson S
    Int J Cardiol; 2016 Feb; 204():88-94. PubMed ID: 26655548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing the safety of treatment for venous thromboembolism in the era of direct oral anticoagulants.
    Weitz JI; Jaffer IH
    Pol Arch Med Wewn; 2016 Sep; 126(9):688-696. PubMed ID: 27592622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Extreme Obesity.
    Russo V; Cattaneo D; Giannetti L; Bottino R; Laezza N; Atripaldi U; Clementi E
    Clin Ther; 2021 Sep; 43(9):e255-e263. PubMed ID: 34366151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of dabigatran and rivaroxaban by ultra-performance liquid chromatography-tandem mass spectrometry and coagulation assays after major orthopaedic surgery.
    Schellings MW; Boonen K; Schmitz EM; Jonkers F; van den Heuvel DJ; Besselaar A; Hendriks JG; van de Kerkhof D
    Thromb Res; 2016 Mar; 139():128-34. PubMed ID: 26916310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials with direct oral anticoagulants for stroke prevention in atrial fibrillation: how representative are they for real life patients?
    Desmaele S; Steurbaut S; Cornu P; Brouns R; Dupont AG
    Eur J Clin Pharmacol; 2016 Sep; 72(9):1125-34. PubMed ID: 27272167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Oral Anticoagulation Therapy After Gastrointestinal Bleeding: Whether to, When to, and How to Restart an Anticoagulation Therapy.
    Kido K; Scalese MJ
    Ann Pharmacother; 2017 Nov; 51(11):1000-1007. PubMed ID: 28639882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of bariatric surgery on direct-acting oral anticoagulant drug levels.
    Rottenstreich A; Barkai A; Arad A; Raccah BH; Kalish Y
    Thromb Res; 2018 Mar; 163():190-195. PubMed ID: 29157916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
    Tummala R; Kavtaradze A; Gupta A; Ghosh RK
    Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US.
    Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M
    J Med Econ; 2015 Jun; 18(6):399-409. PubMed ID: 25586203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A Review.
    Alcocer L
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):171-82. PubMed ID: 26923792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation and BMI: effect of high body weight on the safety and efficacy of direct oral anticoagulants.
    Mausteller KG; Eisele CD; Julian K; Patel P; Bansal A; Jain R; Jain R
    Future Cardiol; 2022 Sep; 18(10):829-837. PubMed ID: 36052844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.